Reports for TEVA-SUCRALFATE
Brand name
TEVA-SUCRALFATE
Company Name
Drug Identification Number
02045702
Ingredients & Strength
ATC Code
- A02BX
- A02BX
ATC Descriptor
- DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
- DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Status
MARKETED
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-SUCRALFATE | 500 | Resolved | 2023-08-17 | 2023-10-04 | 202228 |
| TEVA-SUCRALFATE | 100 | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
| TEVA-SUCRALFATE | 500 | Resolved | 2023-02-16 | 2023-06-09 | 184934 |
| TEVA-SUCRALFATE | 500 | Resolved | 2023-06-16 | 2023-07-21 | 195039 |
| TEVA-SUCRALFATE | 100 | Resolved | 2023-06-16 | 2023-10-04 | 195055 |
| TEVA-SUCRALFATE | 500 | Resolved | 2023-07-27 | 2023-08-04 | 200210 |
| TEVA-SUCRALFATE | 100 | Resolved | 2024-03-07 | 2024-05-30 | 221540 |
| TEVA-SUCRALFATE | 100's & 500's | Actual shortage | 2025-05-05 | 2025-05-08 | 256702 |
| TEVA-SUCRALFATE | 500 | Resolved | 2024-08-30 | 2024-11-08 | 236362 |
| TEVA-SUCRALFATE | 100 | Resolved | 2022-01-27 | 2022-02-25 | 153727 |
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0